@inproceedings{inproceedings, title  = {{Long-term dupilumab treatment is not associated with an increased overall risk of infections in patients aged 6 months to 5 years with moderate-to- severe atopic dermatitis in an open-label extension study}},

 url = {{}},

 year = {{2024}},

 month = {{1}},

 author = {{Paller AS and Ramien M and Cork MJ and Simpson EL and Lee LW and Eichenfield LF and Silva D and Coleman A and Gherardi G and Chen Z and Zhang A et al}},

 volume = {{35}},

 journal = {{PEDIATRIC ALLERGY AND IMMUNOLOGY}},

 note = {{Accessed on 2025/04/22}}}